These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 29724812)
1. USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis. Garcia DA; Baek C; Estrada MV; Tysl T; Bennett EJ; Yang J; Chang JT Mol Cancer Res; 2018 Jul; 16(7):1172-1184. PubMed ID: 29724812 [TBL] [Abstract][Full Text] [Related]
2. USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma. Chen J; Ning D; Du P; Liu Q; Mo J; Liang H; Zhang W; Zhang M; Jiang L; Zhang B; Chen X Oncogene; 2024 Jan; 43(2):123-135. PubMed ID: 37973952 [TBL] [Abstract][Full Text] [Related]
3. USP11 augments TGFβ signalling by deubiquitylating ALK5. Al-Salihi MA; Herhaus L; Macartney T; Sapkota GP Open Biol; 2012 Jun; 2(6):120063. PubMed ID: 22773947 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of USP11 promotes epithelial‑to‑mesenchymal transition by deubiquitinating Snail in ovarian cancer. Wang W; Wang J; Yan H; Zhang K; Liu Y Oncol Rep; 2019 Mar; 41(3):1739-1748. PubMed ID: 30569152 [TBL] [Abstract][Full Text] [Related]
5. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition. Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636 [TBL] [Abstract][Full Text] [Related]
7. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
8. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
9. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells. Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541 [TBL] [Abstract][Full Text] [Related]
10. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386 [TBL] [Abstract][Full Text] [Related]
11. TGFβ and matrix-regulated epithelial to mesenchymal transition. Moustakas A; Heldin P Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266 [TBL] [Abstract][Full Text] [Related]
12. De-ubiquitinating enzyme, USP11, promotes transforming growth factor β-1 signaling through stabilization of transforming growth factor β receptor II. Jacko AM; Nan L; Li S; Tan J; Zhao J; Kass DJ; Zhao Y Cell Death Dis; 2016 Nov; 7(11):e2474. PubMed ID: 27853171 [TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing stromal interaction molecule 2 upregulates nuclear factor of activated T cells 1 and transforming growth factor-β signaling to promote breast cancer metastasis. Miao Y; Shen Q; Zhang S; Huang H; Meng X; Zheng X; Yao Z; He Z; Lu S; Cai C; Zou F Breast Cancer Res; 2019 Aug; 21(1):99. PubMed ID: 31464639 [TBL] [Abstract][Full Text] [Related]
14. Combined Mutation of Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223 [TBL] [Abstract][Full Text] [Related]
15. A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer. Foroutan M; Cursons J; Hediyeh-Zadeh S; Thompson EW; Davis MJ Mol Cancer Res; 2017 May; 15(5):619-631. PubMed ID: 28119430 [TBL] [Abstract][Full Text] [Related]
16. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Tan EJ; Olsson AK; Moustakas A Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613 [TBL] [Abstract][Full Text] [Related]
17. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549 [TBL] [Abstract][Full Text] [Related]
18. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer. Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053 [TBL] [Abstract][Full Text] [Related]
19. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]